Afya appoints Marcelo Ken Suhara as audit committee chair
Afya Limited named Marcelo Ken Suhara as the new Chair of its Audit, Risks and Ethics Committee on July 27, 2026. He replaces João Paulo Seibel de Faria, who died in office. Suhara remains an independent director and financial expert, ensuring stable oversight for the Brazilian medical education provider.
*this image is generated using AI for illustrative purposes only.
Afya Limited (NASDAQ: AFYA, B3: A2FY34) appointed Marcelo Ken Suhara as Chair Member of its Audit, Risks and Ethics Committee on July 27, 2026. The move ensures continuity in oversight for the Brazil-based medical education group following the death of outgoing chair João Paulo Seibel de Faria. Suhara, an independent director, retains his role as an Audit Committee financial expert.
The Board of Directors confirmed the transition after Mr. Faria passed away during his tenure. Management expressed gratitude for Mr. Faria’s contributions to Afya’s governance and extended condolences to his family. Suhara continues to serve as an independent member of the Board alongside his new chairmanship duties.
Afya’s governance structure relies on a diverse Board composition to support decision-making. The body includes two co-chairmen representing Bertelsmann SE & Co. KGaA and the Esteves family, additional directors from both entities, and three independent members. This mix aims to balance stakeholder interests with operational expertise.
Board Composition
| Name | Office |
|---|---|
| Kay Krafft | Co-Chairman of the Board |
| Nicolau Carvalho Esteves | Co-Chairman of the Board |
| Benedikt Dalkmann | Director |
| Christina Krebs | Director |
| Renato Tavares Esteves | Director |
| Marcelo Ken Suhara | Independent Director |
| Vanessa Claro Lopes | Independent Director |
| Miguel Filisbino Pereira de Paula | Independent Director |
Suhara joins Kay Krafft and Nicolau Carvalho Esteves at the top of the leadership hierarchy. The remaining directors include Benedikt Dalkmann and Christina Krebs from Bertelsmann, Renato Tavares Esteves from the Esteves family, and two other independent directors, Vanessa Claro Lopes and Miguel Filisbino Pereira de Paula.
Governance Implications
The appointment stabilizes Afya’s compliance framework during a period of leadership change. As a financial expert on the Audit Committee, Suhara brings specialized oversight to the company’s financial reporting and risk management processes. This continuity is critical for maintaining investor confidence in Afya’s disclosure practices.
Afya operates as a leading medical education group in Brazil, measured by the number of medical school seats. Its ecosystem supports students and physicians through residency preparation, graduation programs, continuing medical education, and practice solutions. Strong governance underpins the trust required to serve this long-term career lifecycle.
How might the transition of Audit Committee leadership impact Afya's upcoming quarterly financial disclosures and investor confidence?
Does Marcelo Ken Suhara's dual role as an independent director and Audit Committee chair present any potential conflicts of interest or governance challenges?
What specific risk management strategies is Afya prioritizing under Suhara's oversight given the current regulatory environment for medical education in Brazil?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
